Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2020

Feb 14, 2020

30237_dirs_2020-02-14_aeab96dc-382e-411a-abd1-0244a525a912.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2020-02-12

Reporting Person: KING DAVID P (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-02-12 Common Stock M 3513 Acquired 312436.1345 Direct
2020-02-12 Common Stock F 1386 $187.51 Disposed 311050.1345 Direct
2020-02-12 Common Stock M 4236 Acquired 315286.1345 Direct
2020-02-12 Common Stock F 1894 $187.51 Disposed 313392.1345 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-02-12 Restricted Stock Unit $ M 3513 Disposed Common Stock (3513) Direct
2020-02-12 Restricted Stock Unit $ M 4236 Disposed Common Stock (4236) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 19542 Indirect

Footnotes

F1: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F2: Stock withholding to satisfy tax withholding obligations.

F3: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2019.

F4: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

F5: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 12, 2020.